CTOs on the Move

SpineGuard

www.spineguard.com

 
Founded in 2009 in France and the USA by Pierre Jerome and Stephane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 80,000 surgical procedures worldwide. Sixteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.spineguard.com
  • 1434 Spruce Street Suite 100
    Boulder, CO USA 80302
  • Phone: 720.726.8085

Executives

Name Title Contact Details

Similar Companies

Xodus Medical

Xodus Medical is a New Kensington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Air Equipment Rental Corp

Air Equipment Rental Corp is a Fairfield, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Claghorn-Lesem Research Clinic

Claghorn-Lesem Research Clinic is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SaluMedica

SaluMedica is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.